Barry E. Greene - President and CEO, Director at Sage Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
SAGE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Barry E. Greene since 4/23/2024

Holdings reported by Barry E. Greene for Sage Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 100K $692K $6.91 Apr 10, 2025 Direct
Stock Option (Right to Buy) 174K Jan 16, 2025 Direct Common Stock

Transactions reported by Barry E. Greene for Sage Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.